«Fra-2, Fra-2, a new therapeutic target in lung cancer and its microenvironment». (PI21/01997) Instituto de Salud Carlos III. Principal Investigator: Álvaro Ucero. 01/01/2022- 31/12/2024. 135.520 €.
This web site uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and accepting our cookies policy, click the link for more information.plugin cookies